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Endocrine surgery has steadily evolved from relative obscurity into 
a well-defined subdiscipline of general surgery. Success in this area 
relies on close co-operation with endocrinologists, radiologists, 
nuclear physicians, and pathologists. Endocrine surgeons have 
a pivotal role in the management of nodular thyroid disease and 
thyroid cancer, hyperparathyroidism, as well as functional adrenal 
and pancreatic tumours. 
Unlike other solid tumours, endocrine neoplasms make their 
presence known by systemic effects of excess hormone production, 
rather than by local symptoms related to tumour size or local 
invasion. As laboratory diagnostic methods and radiology imaging 
techniques have improved, so the demand for surgical expertise in 
this area has increased.  
Techniques of minimally invasive surgery have transformed the 
practice of general surgery. In some cases, such as cholecystectomy 
or anti-reflux surgery, laparoscopy has become the unquestioned 
standard of care; in others, such as hernia or colorectal surgery 
the debate continues.  In this article I will describe the role such 
techniques have to play in the surgical management of endocrine 
conditions.
Adrenal
Adrenalectomy is performed for cure of adrenal causes of Conn’s 
and Cushing’s syndrome, phaeochromocytoma, as well as incidental 
adrenal tumours. Laparoscopic removal is unquestionably the 
approach of choice for most of these.1 The adrenal is a small, 
relatively inaccessible gland tucked away on top of the kidney in 
the retroperitoneum, in close proximity to the liver, infererior vena 
cava (IVC) on the right, and aorta, spleen, and pancreas on the 
left. Open removal requires a large incision to expose the anatomy 
safely, yet the tumours are frequently quite small, often less than 5 
cm in diameter. A generous surgical exposure is therefore needed 
to remove a small pathological organ. Laparoscopy circumvents 
these difficulties neatly and effectively.
Most laparoscopic adrenalectomies are performed via a 
transperitoneal approach with the patient in a 90 degree lateral 
position.
An alternative is a completely retroperitoneal approach, done with 
the patient in a prone position, via posteriorly placed ports. The 
final decision rests with the surgeon, and there is not much to 
choose in terms of outcome benefits. There is a wealth of published 
information available supporting the use and benefits of minimal 
access surgery in this context, and in most cases patients are 
discharged within 48 hours of surgery, with little morbidity and 
minimal mortality.2 
The debate of ‘laparoscopic versus open adrenalectomy’ is out of 
date and is replaced by issues on what cases to select for an open 
approach de novo – my practice is to consider all adrenal masses 
under 10 cm for a laparoscopic approach unless the preoperative 
images suggest invasion or unequivocal malignancy. For larger 
lesions I use a laparotomy via a subcostal incision, reserving a 
thoraco-abdominal approach for the truly massive tumours, i.e. 
larger than 15 - 20 cm.
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Fig. 1. CT scan of the abdomen illustrating a 7 cm phaeochromocytoma 
in the left adrenal gland.
Fig. 2. The patient is in the left lateral position, 4 ports are placed 
subcostally.
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Thyroid
The technique of thyroidectomy was 
described as early as 937AD in China. 
Kocher developed it into a safe operation at 
the turn of last century and received a Nobel 
prize for his work. The surgical approach 
to thyroid has been largely unchanged 
since, until minimally invasive techniques 
arrived on the scene. Husher3 was the first 
to perform a videoscopic thyroidectomy. 
There are 2 types of operations. The first 
minimises the incision but keeps it in the 
neck. The best studied is the video-assisted 
central neck access approach, described by 
Miccoli from Pisa, Italy.4 The other type, 
performed mostly in Asian countries, 
moves the incision from the neck and 
places it at cosmetically hidden sites, 
such as the axilla, periareola and breast 
skin folds. Here, ports are placed and 
instruments tunneled to the neck where 
the operation is done under complete 
video guidance. The main advantage of 
this is that it is completely scar free in the 
neck. Both these approaches have been 
shown by their proponents to be safe and 
technically feasible. Their main advantage 
over conventional approaches is only 
cosmetic, and since most thyroid surgery 
can be done with a small incision anyway, 
usually well hidden in a skin crease in 
the neck, critics argue that it may not be 
a significant advantage over conventional 
practice at present. 
Parathyroid
Parathyroidectomy has moved from 
mandatory 4-gland exploration to a 
selective, minimally invasive approach. 
This has been facilitated by accurate 
preoperative imaging that allows the 
surgeon to explore the affected gland 
only. The imaging modality of choice is 
a nuclear medicine sestamibi scan (with 
approximately 80% accuracy), and some 
surgeons also use neck ultrasonography. 
If the nuclear scan and ultrasound are 
concordant a focused exploration can be 
undertaken with a confident expectation 
of success. A further adjunct to focused 
exploration is the use of intraoperative 
parathyroid hormone (PTH) testing. This 
was first proposed by Irving et al.5 from 
Florida, and has found many supporters 
in practice worldwide. Newer PTH assays 
can give a result within 15 - 20 minutes 
Since PTH has a very short half life, 
confirming an immediate drop in PTH 
values correlates well with long-term cure 
of the condition. 
All of the above have allowed surgeons to 
perform more focused surgery without 
compromising long-term results. Patients 
benefit by having smaller incisions, 
less dissection, and generally an easier 
postoperative recovery. In selected cases 
a parathyroidectomy can be done under 
local or regional anaesthesia, clearly an 
advantage in very elderly or unfit patients. 
A number of other gadgets have also staked 
their claim in this operation, mostly with 
little success. Neck surgery can be done 
via trochars inserted at differing sites, 
and under video guidance – this is the 
video-assisted parathyroidectomy.6 Since a 
parathyroidectomy can be performed with 
a limited skin incision under direct vision 
anyway, the advantages of the video-
assisted approach are difficult to prove, 
and this technique remains in the hands 
of a few enthusiasts only. Another option 
to aid the intraoperative localisation of a 
parathyroid adenoma is the hand-held 
gamma camera. This tool is commonly 
used in the detection of sentinel lymph 
nodes, and can be easily used via small 
skin incisions. The technique relies on 
a preoperative injection of sestamibi, 
which would then be taken up by the 
abnormal adenoma within 2 - 3 hours of 
its administration.
If the operation is timed appropriately the 
excess radiation emitted by the adenoma 
can be located by the gamma camera, 
thus helping to identify the adenoma. I 
find this an awkward adjunct to surgical 
exploration, and it has a role mostly in 
complex repeat explorations, rather than 
in routine cases.
Conclusion
Minimally invasive surgery is the standard 
for routine adrenalectomy; minimally 
invasive parathyroidectomy is becoming 
a standard with the traditional bilateral 
exploratory  procedures; minimally 
invasive thyroidectomy is still more hype 
than standard of treatment.1 As localisation 
and minimally invasive techniques 
continue to evolve, we will see the frontier 
of minimally invasive endocrine surgery 
continue to advance.
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Fig. 3. Sestamibi scan allowing confident 
preoperative loclaisation of a parathyroid 
adenoma located in the left lower position. 
This was removed successfully with a limited 
exploration.
In a nutshell 
The common themes that emerge in minimally invasive endocrine surgery are that:  
•    proper patient selection is crucial to good results 
•    it is best to localise the tumours preoperatively whenever possible for a focused operation 
•    invasive cancers and very large tumours are usually contraindications to minimally invasive approaches 
•    multiple techniques are usually available, although some may be more versatile than others 
•    surgeon and institutional experience is of paramount importance in the choice of specific surgical technique and in obtaining good 
results 
•    good prospective studies are sorely needed to evaluate these techniques. 
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